Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Devos

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 3, 2009
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's diseaseDavid Devos,
The Lancet. Neurology|June 20, 2012
David DevosDavid Devos
The Lancet. Neurology|January 5, 2016
Opicapone for motor fluctuations in Parkinson's diseaseDavid Devos, Caroline Moreau
Brain : a Journal of Neurology|September 14, 2014
Genetic characterization of cognitive impairment in Parkinson's diseaseKathy Dujardin, David Devos
The Lancet. Neurology|January 23, 2016
Acetylcholinesterase inhibitors and gait: a steadying hand?Caroline Moreau, David Devos, Luc Defebvre
The New England Journal of Medicine|February 28, 2009
Levodopa for Parkinson's diseaseDavid Devos, Caroline Moreau, Alain Destée
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2020
Seven Solutions for Neuroprotection in Parkinson's DiseaseDavid Devos, Etienne Hirsch, Richard Wyse
Journal of Parkinson'S Disease|June 7, 2024
Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/PharmacodynamicsAlexandre Demailly, Caroline Moreau, David Devos
Fundamental & Clinical Pharmacology|February 19, 2010
Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's diseaseDavid Devos, L Defebvre, R Bordet
Neurology|September 29, 2017
Virtually reducing fall risk in Parkinson diseaseCaroline Moreau, Brandon R Barton, David Devos
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Movement Disorders : Official Journal of the Movement Disorder Society|March 3, 2009
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's diseaseDavid Devos,
The Lancet. Neurology|June 20, 2012
David DevosDavid Devos
The Lancet. Neurology|January 5, 2016
Opicapone for motor fluctuations in Parkinson's diseaseDavid Devos, Caroline Moreau
Brain : a Journal of Neurology|September 14, 2014
Genetic characterization of cognitive impairment in Parkinson's diseaseKathy Dujardin, David Devos
The Lancet. Neurology|January 23, 2016
Acetylcholinesterase inhibitors and gait: a steadying hand?Caroline Moreau, David Devos, Luc Defebvre
The New England Journal of Medicine|February 28, 2009
Levodopa for Parkinson's diseaseDavid Devos, Caroline Moreau, Alain Destée
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2020
Seven Solutions for Neuroprotection in Parkinson's DiseaseDavid Devos, Etienne Hirsch, Richard Wyse
Journal of Parkinson'S Disease|June 7, 2024
Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/PharmacodynamicsAlexandre Demailly, Caroline Moreau, David Devos
Fundamental & Clinical Pharmacology|February 19, 2010
Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's diseaseDavid Devos, L Defebvre, R Bordet
Neurology|September 29, 2017
Virtually reducing fall risk in Parkinson diseaseCaroline Moreau, Brandon R Barton, David Devos
Pageof 22